REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies)

RecruitingOBSERVATIONAL
Enrollment

500

Participants

Timeline

Start Date

September 16, 2022

Primary Completion Date

February 28, 2026

Study Completion Date

June 22, 2029

Conditions
Infertility
Trial Locations (1)

Unknown

RECRUITING

Ferring Investigational Site, Omitama

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY

NCT06545877 - REKOVELLE PEN for S.C. Injection General Drug Use Survey (Controlled Ovarian Stimulation in Assisted Reproductive Technologies) | Biotech Hunter | Biotech Hunter